Prot #D0818C00001/GOG-3004: A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chem

Project: Research project

StatusFinished
Effective start/end date6/19/148/31/18

Funding

  • DrugDev Inc. (Prot #D0818C00001/GOG-3004)
  • AstraZeneca Pharmaceuticals LP (Prot #D0818C00001/GOG-3004)